| 2025-11-13 |
详情>>
内部人交易：
Hunt Jonathan Robert股份增加11000.00股
|
| 2025-11-10 |
详情>>
股本变动：
变动后总股本7433.80万股
变动原因 ▼▲
- 原因：
- From June 30, 2025 to September 30, 2025
Issuance of common stock pursuant to the exercise of options
|
| 2025-11-10 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.89美元,归母净利润-6563.1万美元,同比去年增长-67.81%
|
| 2025-11-10 |
财报披露：
美东时间 2025-11-10 盘后发布财报
|
| 2025-08-13 |
详情>>
业绩披露：
2025年中报每股收益-0.54美元,归母净利润-3966.2万美元,同比去年增长-65.34%
|
| 2025-05-12 |
详情>>
业绩披露：
2025年一季报每股收益-0.25美元,归母净利润-1817.7万美元,同比去年增长-47.97%
|
| 2025-04-16 |
股东大会：
将于2025-05-28召开股东大会
会议内容 ▼▲
- 1.To elect five directors to the Company’s board of directors (the “Election Proposal”);
2.To ratify the appointment of WithumSmith+Brown, PC (“Withum”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025 (the “Auditor Ratification Proposal”);
3.To conduct a non-binding advisory vote to approve the compensation of our named executive officers (the “Say on Pay Proposal”);
4.To conduct any other business properly brought before the Annual Meeting.
|
| 2025-03-28 |
详情>>
业绩披露：
2024年年报每股收益-1.23美元,归母净利润-7927.9万美元,同比去年增长-70.46%
|
| 2024-11-21 |
复牌提示：
2024-11-21 09:43:25 停牌，复牌日期 2024-11-21 09:48:25
|
| 2024-11-12 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.62美元,归母净利润-3911万美元,同比去年增长-79.13%
|
| 2024-08-13 |
详情>>
业绩披露：
2023年中报每股收益-0.45美元,归母净利润-1147.7万美元,同比去年增长-235.09%
|
| 2024-08-13 |
详情>>
业绩披露：
2024年中报每股收益-0.41美元,归母净利润-2398.8万美元,同比去年增长-109.01%
|
| 2024-06-11 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2024-05-15 |
详情>>
业绩披露：
2024年一季报每股收益-0.02美元,归母净利润-1228.4万美元,同比去年增长-3211.05%
|
| 2024-04-18 |
股东大会：
将于2024-05-31召开股东大会
会议内容 ▼▲
- 1.To elect five directors to the Company’s board of directors (the “Election Proposal”);
2.To approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company’s outstanding shares of common stock at a ratio of 1:10 (the “Reverse Stock Split”), with such reverse stock split to be effected at such time and date, if at all, as determined by the Company’s board of directors in its sole discretion (the “Reverse Stock Split Proposal”);
3.To ratify the appointment of WithumSmith+Brown, PC (“Withum”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 (the “Auditor Ratification Proposal”);
4.To approve the Company’s Third Amended and Restated 2020 Equity Incentive Plan (the “Plan”) (the “Equity Incentive Plan Proposal”);
5.To conduct any other business properly brought before the Annual Meeting.
|
| 2023-11-14 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.08美元,归母净利润-2183.3万美元,同比去年增长-191.38%
|
| 2023-08-22 |
股东大会：
将于2023-10-06召开股东大会
会议内容 ▼▲
- 1.To consider and vote on a proposal to elect five directors of Perspective Therapeutics Inc., a Delaware corporation (“Perspective” or the “Company”) to hold office until the Company’s 2024 Annual Meeting of Stockholders and until his or her successor has been elected and qualified (the “Election Proposal”).
2.To consider and vote on a proposal to ratify the appointment of Assure CPA, LLC as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2023 (the “Auditor Ratification Proposal”).
3.To consider and vote on a proposal to approve the Company’s Second Amended and Restated 2020 Equity Incentive Plan (the “Equity Incentive Plan Proposal”).
4.To take action on any other business that may properly be considered at the Annual Meeting or any adjournment thereof.
|
| 2022-11-07 |
股东大会：
将于2022-12-13召开股东大会
会议内容 ▼▲
- 1.To consider and vote on a proposal (the “Certificate Amendment Proposal”) to approve an amendment to the Company’s Certificate of Incorporation to increase the total number of authorized shares of Common Stock to 750,000,000 shares.
2.To consider and vote on a proposal (the “NYSE American Proposal”), for purposes of complying with applicable NYSE American rules, to approve the issuance by the Company of shares of Common Stock, par value $0.001 per share, in an amount equal to 20% or more of the amount of Company Common Stock issued and outstanding immediately prior to such issuance pursuant to the terms of the Merger Agreement, in an amount necessary to complete the Merger and the other transactions contemplated by the Merger Agreement.
3.To consider and vote on a proposal (the “Equity Incentive Plan Amendment Proposal”) to approve an amendment to the Company’s Amended and Restated 2020 Equity Incentive Plan (the “Plan”) to increase the total number of shares of common stock available for awards under the Plan to 46,000,000 shares.
4.To consider and vote on a proposal (the “Election Proposal”) to approve the election of four directors to hold office until the Fiscal 2024 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified.
5.To ratify the appointment of Assure CPA, LLC as the independent registered public accounting firm of the Company for the fiscal year ending June 30, 2023 (the “Auditor Ratification Proposal”).
6.To hold an advisory vote to approve the compensation of the Company’s named executive officers as disclosed pursuant to the compensation rules of the Securities and Exchange Commission in this Proxy Statement under the caption “Executive Compensation” (the “Say-on-Pay Proposal”).
7.To consider and vote on a proposal (the “Adjournment Proposal”) to approve the adjournment of the Annual Meeting, if necessary, to ensure that any necessary supplement or amendment to the Proxy Statement accompanying this notice is provided to the Company’s stockholders a reasonable amount of time in advance of the Annual Meeting or to solicit additional proxies if there are insufficient votes at the time of the Annual Meeting to approve adoption of the NYSE American Proposal, the Equity Incentive Plan Amendment Proposal, or the Certificate Amendment Proposal;
8.To take action on any other business that may properly be considered at the Annual Meeting or any adjournment thereof.
|
| 2021-10-25 |
股东大会：
将于2021-12-07召开股东大会
会议内容 ▼▲
- 1.To elect four directors to hold office until the Fiscal 2023 Annual Meeting of Stockholders.
2.To ratify the appointment of Assure CPA, LLC (formerly known as DeCoria, Maichel & Teague, P.S.) as the independent registered public accounting firm of the Company for the fiscal year ending June 30, 2022.
3.To approve the Company’s Amended and Restated 2020 Equity Incentive Plan.
4.To take action on any other business that may properly be considered at the Annual Meeting or any adjournment thereof.
|
| 2020-10-27 |
股东大会：
将于2020-12-08召开股东大会
会议内容 ▼▲
- 1.To elect four directors to hold office until the Fiscal 2022 Annual Meeting of Stockholders.
2.To ratify the appointment of DeCoria, Maichel & Teague, P.S. as the independent registered public accounting firm of the Company for the fiscal year ending June 30, 2021.
3.To hold an advisory vote on whether the Company should include an advisory vote of the stockholders on the compensation of the Company's named executive officers pursuant to Section 14A of the Securities Exchange Act every one, two, or three years.
4.To take action on any other business that may properly be considered at the Annual Meeting or any adjournment thereof.
|
| 2019-10-25 |
股东大会：
将于2019-12-10召开股东大会
会议内容 ▼▲
- 1.To elect four directors to hold office until the Fiscal 2021 Annual Meeting of Stockholders.
2.To ratify the appointment of DeCoria, Maichel & Teague, P.S. as the independent registered public accounting firm of the Company for the fiscal year ending June 30, 2020.
3.To hold an advisory vote to approve the compensation of the Company’s named executive officers as disclosed pursuant to the compensation rules of the Securities and Exchange Commission in this Proxy Statement under the caption “Executive Compensation”.
4.To approve the 2020 Equity Incentive Plan.
5.To take action on any other business that may properly be considered at the Annual Meeting or any adjournment thereof.
|
| 2018-11-09 |
股东大会：
将于2018-12-18召开股东大会
会议内容 ▼▲
- 1.To elect four directors to hold office until the Fiscal 2020 Annual Meeting of Shareholders.
2.To ratify the appointment of DeCoria, Maichel & Teague, P.S. as the independent registered public accounting firm of the Company for the fiscal year ending June 30, 2019.
3.To approve the proposal to reincorporate the Company from Minnesota to Delaware.
4.To take action on any other business that may properly be considered at the Annual Meeting or any adjournment thereof.
|
| 2017-11-03 |
股东大会：
将于2017-12-14召开股东大会
会议内容 ▼▲
- 1. To elect four directors to hold office until the Fiscal 2019 Annual Meeting of Shareholders.
2. To ratify the appointment of DeCoria, Maichel & Teague, P.S. as the independent registered public accounting firm of the Company for the fiscal year ending June 30, 2018.
3. To take action on any other business that may properly be considered at the Annual Meeting or any adjournment thereof.
|
| 2017-05-17 |
股东大会：
将于2017-06-15召开股东大会
会议内容 ▼▲
- 1.To approve the Company’s 2014 Employee Stock Option Plan;
2.To approve the stock options granted under the 2014 Employee Stock Option Plan;
3.To approve the Company’s 2017 Equity Incentive Plan;
4.To ratify the appointment of DeCoria, Maichel & Teague, P.S. as the independent registered public accounting firm of the Company for the fiscal year ending June 30, 2018.
|
| 2016-11-04 |
股东大会：
将于2016-12-14召开股东大会
会议内容 ▼▲
- 1. To elect four directors to hold office until the Fiscal 2018 Annual Meeting of Shareholders;
2. To ratify the appointment of DeCoria, Maichel & Teague, P.S. as the independent registered public accounting firm of the Company for the fiscal year ending June 30, 2017;
3. Hold an advisory vote to approve the compensation of the Company's named executive officers as disclosed pursuant to the compensation rules of the Securities and Exchange Commission in this Proxy Statement under the caption "Executive Compensation;"
4. To take action on any other business that may properly be considered at the Annual Meeting or any adjournment thereof.
|
| 2016-04-29 |
股东大会：
将于2016-06-08召开股东大会
会议内容 ▼▲
- 1.To elect four directors to hold office until the Fiscal 2017 Annual Meeting of Shareholders;
2.To approve the Company’s 2016 Equity Incentive Plan;
3.To ratify the appointment of DeCoria, Maichel & Teague, P.S. as the independent registered public accounting firm of the Company for the fiscal year ending June 30, 2016;
4.To take action on any other business that may properly be considered at the Annual Meeting or any adjournment thereof.
|